glp 1 vs sglt2 weight loss SGLT2i and GLP-1 RA therapy in type diabetes and reno-vascular outcomes: a real-world study | Diabetologia Safety, efficacy, and cardiovascular benefits

.

Does anyone knows of a link to information on this

Therapeutic efforts should move beyond broad-spectrum agents toward highly specific modulators, including structure-guided inhibitors of core regulators such as GPX4, emerging modalities such as PROTAC-based approaches to selectively degrade pro-ferroptotic proteins, and targeted nanomedicine systems for site-specific delivery

Potheher, Synthesis of ZnO nanoparticles using leaf extract of Tectona grandis (L.) and their anti-bacterial, anti-arthritic, anti-oxidant and in vitro cytotoxicity activities

Anaerobic Bacteroides, Bifidobacteria, Eubacteria, Streptococcus and lactobacillus are the main bacteria that produce SCFAs

g , Mapping of the disease-associated variants onto the GSSG-bound SLC33A1 structure